Komori
Other Disclosures3591WACOAL HOLDINGS CORP.Materials and Chemicals

Wacoal Human Science Research & Development Center establishes an R&D base in the United States — Accelerating global research and development by leveraging anthropometric data

Wacoal’s US subsidiary will establish the “Human Science Research & Development Center-America” in New York, United States, effective 1 October 2026. The center will be equipped with the body-scanning service “SCANBE” and is scheduled to begin full-scale operations in November 2026.

Worth reading
71In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
3
Number of R&D bases worldwide (bases)
Wording
Conditional
How definitive the wording is.

Announced details

Human Science Research & Development Center-AmericaSCANBE (body-scanning service)CW-X
Applicable field (uses covered by this announcement)
Research and DevelopmentProduct DevelopmentSize designQuality ImprovementSportsMedical Field
Launch dateThe Human Science Research & Development Center-America is scheduled to be established on 1 October 2026. SCANBE is scheduled to begin full-scale operations in November 2026.
What the company reported numerically
Usage history

Wacoal’s Human Science Research and Development Center in Japan has accumulated anthropometric data on approximately 45,000 or more women. This will be the group’s third human science R&D base worldwide, following Japan and China.

Relationship between the counterparty and the company
WACOAL HOLDINGS CORP.3591
Relationship with the Company

Wacoal’s US subsidiary is a consolidated subsidiary of WACOAL HOLDINGS CORP. It shares research assets and expertise with Wacoal’s Human Science Research and Development Center in Japan as part of the group.

Location (as indicated in this announcement)

136 Madison Avenue New York, N.Y. 10016 U.S.A.

Impact on Business Performance

The company expects this to improve competitiveness in its overseas business and contribute to the creation of value through new products and services, but has not disclosed a specific financial impact.

The company does not address Contract Value / Offering price.

Announced details
ItemDetails
Names of Products / Services CoveredHuman Science Research & Development Center-America, SCANBE (body-scanning service), CW-X
Relationship with the CompanyWacoal’s US subsidiary is a consolidated subsidiary of WACOAL HOLDINGS CORP. It shares research assets and expertise with Wacoal’s Human Science Research and Development Center in Japan as part of the group.
Launch dateThe Human Science Research & Development Center-America is scheduled to be established on 1 October 2026. SCANBE is scheduled to begin full-scale operations in November 2026.
Applicable areaResearch and Development, Product Development, Size design, Quality Improvement, Sports, Medical Field
Location136 Madison Avenue New York, N.Y. 10016 U.S.A.
Usage historyWacoal’s Human Science Research and Development Center in Japan has accumulated anthropometric data on approximately 45,000 or more women. This will be the group’s third human science R&D base worldwide, following Japan and China.
Impact on Business PerformanceThe company expects this to improve competitiveness in its overseas business and contribute to the creation of value through new products and services, but has not disclosed a specific financial impact.
Items this document does not state (11)
CounterpartyCounterparty overviewContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocation scaleQuantitative EffectsSource

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

To strengthen global R&D capabilities by combining anthropometric data and research expertise accumulated in Japan with data obtained in the US market. The company aims to deepen its understanding of physical characteristics and customers in the US market and use this to improve the competitiveness of product development, research activities and overseas operations.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Wacoal Human Science Research & Development Center establishes an R&D base in the United States — Accelerating global research and development by leveraging anthropometric data | WACOAL HOLDINGS CORP. (3591) timely disclosure | Komori